122 related articles for article (PubMed ID: 37336300)
1. 4D printed multipurpose smart implants for breast cancer management.
Moroni S; Bingham R; Buckley N; Casettari L; Lamprou DA
Int J Pharm; 2023 Jul; 642():123154. PubMed ID: 37336300
[TBL] [Abstract][Full Text] [Related]
2. Cellulose Nanocrystals-Incorporated Thermosensitive Hydrogel for Controlled Release, 3D Printing, and Breast Cancer Treatment Applications.
Phan VHG; Murugesan M; Huong H; Le TT; Phan TH; Manivasagan P; Mathiyalagan R; Jang ES; Yang DC; Li Y; Thambi T
ACS Appl Mater Interfaces; 2022 Sep; 14(38):42812-42826. PubMed ID: 36112403
[No Abstract] [Full Text] [Related]
3. Evaluation of doxorubicin-loaded pH-sensitive polymeric micelle release from tumor blood vessels and anticancer efficacy using a dorsal skin-fold window chamber model.
Jin ZH; Jin MJ; Jiang CG; Yin XZ; Jin SX; Quan XQ; Gao ZG
Acta Pharmacol Sin; 2014 Jun; 35(6):839-45. PubMed ID: 24902790
[TBL] [Abstract][Full Text] [Related]
4. 3D and 4D Printing in the Fight against Breast Cancer.
Moroni S; Casettari L; Lamprou DA
Biosensors (Basel); 2022 Jul; 12(8):. PubMed ID: 35892465
[TBL] [Abstract][Full Text] [Related]
5. Smart implants: 4D-printed shape-morphing scaffolds for medical implantation.
Qu G; Huang J; Gu G; Li Z; Wu X; Ren J
Int J Bioprint; 2023; 9(5):764. PubMed ID: 37457930
[TBL] [Abstract][Full Text] [Related]
6. Engineering of Micro- to Nanostructured 3D-Printed Drug-Releasing Titanium Implants for Enhanced Osseointegration and Localized Delivery of Anticancer Drugs.
Maher S; Kaur G; Lima-Marques L; Evdokiou A; Losic D
ACS Appl Mater Interfaces; 2017 Sep; 9(35):29562-29570. PubMed ID: 28820570
[TBL] [Abstract][Full Text] [Related]
7. Synthesis, characterization, and biological verification of anti-HER2 indocyanine green-doxorubicin-loaded polyethyleneimine-coated perfluorocarbon double nanoemulsions for targeted photochemotherapy of breast cancer cells.
Lee YH; Ma YT
J Nanobiotechnology; 2017 May; 15(1):41. PubMed ID: 28521752
[TBL] [Abstract][Full Text] [Related]
8. Liposomes co-encapsulating doxorubicin and glucoevatromonoside derivative induce synergic cytotoxic response against breast cancer cell lines.
Novais MVM; Gomes ER; Miranda MC; Silva JO; Gomes DA; Braga FC; Pádua RM; Oliveira MC
Biomed Pharmacother; 2021 Apr; 136():111123. PubMed ID: 33486211
[TBL] [Abstract][Full Text] [Related]
9. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
10. Bacterial cellulose hydrogel loaded with lipid nanoparticles for localized cancer treatment.
Cacicedo ML; Islan GA; León IE; Álvarez VA; Chourpa I; Allard-Vannier E; García-Aranda N; Díaz-Riascos ZV; Fernández Y; Schwartz S; Abasolo I; Castro GR
Colloids Surf B Biointerfaces; 2018 Oct; 170():596-608. PubMed ID: 29975908
[TBL] [Abstract][Full Text] [Related]
11. Drug-loaded implantable surgical cavity-adaptive hydrogels for prevention of local tumor recurrence.
Zhuang B; Chen T; Xiao Z; Jin Y
Int J Pharm; 2020 Mar; 577():119048. PubMed ID: 31978462
[TBL] [Abstract][Full Text] [Related]
12. Significant advancements of 4D printing in the field of orthopaedics.
Javaid M; Haleem A
J Clin Orthop Trauma; 2020 Jul; 11(Suppl 4):S485-S490. PubMed ID: 32774016
[TBL] [Abstract][Full Text] [Related]
13. Oncoplastic breast-conserving surgery for women with primary breast cancer.
Nanda A; Hu J; Hodgkinson S; Ali S; Rainsbury R; Roy PG
Cochrane Database Syst Rev; 2021 Oct; 10(10):CD013658. PubMed ID: 34713449
[TBL] [Abstract][Full Text] [Related]
14. Mixed micelles for encapsulation of doxorubicin with enhanced in vitro cytotoxicity on breast and ovarian cancer cell lines versus Doxil
Cagel M; Bernabeu E; Gonzalez L; Lagomarsino E; Zubillaga M; Moretton MA; Chiappetta DA
Biomed Pharmacother; 2017 Nov; 95():894-903. PubMed ID: 28903185
[TBL] [Abstract][Full Text] [Related]
15. Local penetration of doxorubicin via intrahepatic implantation of PLGA based doxorubicin-loaded implants.
Gao L; Li Q; Zhang J; Huang Y; Deng L; Li C; Tai G; Ruan B
Drug Deliv; 2019 Dec; 26(1):1049-1057. PubMed ID: 31691602
[TBL] [Abstract][Full Text] [Related]
16. A nanoparticle-containing polycaprolactone implant for combating post-resection breast cancer recurrence.
Gao Y; Wang J; Han H; Xiao H; Jin WK; Wang S; Shao S; Wang Z; Yang W; Wang L; Weng L
Nanoscale; 2021 Sep; 13(34):14417-14425. PubMed ID: 34473184
[TBL] [Abstract][Full Text] [Related]
17. Co-delivery of cisplatin and doxorubicin by covalently conjugating with polyamidoamine dendrimer for enhanced synergistic cancer therapy.
Guo XL; Kang XX; Wang YQ; Zhang XJ; Li CJ; Liu Y; Du LB
Acta Biomater; 2019 Jan; 84():367-377. PubMed ID: 30528609
[TBL] [Abstract][Full Text] [Related]
18. 4D Printing Applications in the Development of Smart Cardiovascular Implants.
Kabirian F; Mela P; Heying R
Front Bioeng Biotechnol; 2022; 10():873453. PubMed ID: 35694223
[TBL] [Abstract][Full Text] [Related]
19. Multidisciplinary management of mammary Paget's disease: recommendations to optimize oncological and aesthetic outcomes.
Franceschini G; Mason EJ; Di Leone A; Scardina L; Masetti R
Ann Ital Chir; 2022; 93():481-482. PubMed ID: 36196555
[TBL] [Abstract][Full Text] [Related]
20. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
